Catégorie

algemeen

300 substances · triables par notifications, ROR ou % graves.

affichage de 300 sur 300

Produit ↓	Notifications	% graves	Signal principal	ROR	Type
zolpidem tartrate —	132 956	69.3%	Suicide accompli	8.5	drug
x-ray —	160 318	1.8%	—	—	device
wearable cardioverter defibrillator —	144 009	27.1%	—	—	device
warfarin —	126 794	79.5%	augmentation du ratio international normalisé	100.9	drug
vitamin —	120 098	59.0%	Réaction liée à la perfusion	8.6	drug
ventilator, non-continuous (respirator) —	273 528	20.7%	—	—	device
ventilator, non-continuous —	276 461	20.8%	—	—	device
ventilator, continuous, facility use —	124 158	6.3%	—	—	device
ventilator, continuous, facility —	129 333	6.3%	—	—	device
ventilator, continuous —	190 641	5.6%	—	—	device
ventilator —	517 948	14.6%	—	—	device
venlafaxine hydrochloride —	129 795	74.2%	syndrome sérotoninergique	24.2	drug
venlafaxine —	129 795	74.2%	syndrome sérotoninergique	24.2	drug
valve —	180 969	83.5%	—	—	device
valsartan —	242 787	65.0%	Hypotension	7.2	drug
ustekinumab —	100 563	59.1%	Anticorps anti-peptide cyclique citrulliné positif	220.1	drug
unvented volume infusion set with "y" sites —	25 000 507	0.1%	—	—	device
treprostinil —	121 655	57.6%	douleur au site de perfusion	144.1	drug
topiramate —	97 078	65.4%	Épilepsie	13.4	drug
tofacitinib —	185 980	48.6%	Déformation de la main	149.2	drug
tocilizumab —	112 048	76.6%	Anticorps anti-peptide cyclique citrulliné positif	1109.5	drug
tiotropium bromide —	150 254	50.2%	voie d'administration du médicament incorrecte	297.6	drug
teriparatide —	111 637	37.1%	augmentation du calcium sanguin	58.0	drug
tadalafil —	98 103	62.5%	Hypertension artérielle pulmonaire	53.3	drug
tacrolimus extended-release capsules —	120 821	90.5%	Néphropathie associée aux polyomavirus	465.4	drug
tacrolimus —	152 389	89.9%	Néphropathie associée aux polyomavirus	498.4	drug
system, peritoneal, automatic delivery —	151 392	12.9%	—	—	device
suture —	190 872	47.8%	—	—	device
stimulator, spinal-cord, totally implanted for pain relief —	127 323	64.4%	—	—	device
stimulator, spinal-cord, totally implanted for —	172 949	55.4%	—	—	device
sterile disposable 1/4 x 1/4 x 1/4 "y" connector —	25 000 665	0.4%	—	—	device
sterile disposable "x" "x" "y" connector —	25 001 792	0.4%	—	—	device
stent —	201 113	54.7%	—	—	device
staple, implantable —	148 798	15.4%	—	—	device
spironolactone —	137 410	78.5%	hyperkaliémie	26.3	drug
sodium chloride —	264 849	82.0%	péritonite	19.4	drug
simvastatin —	261 343	72.2%	rhabdomyolyse	13.0	drug
sildenafil citrate —	125 270	66.5%	Augmentation de l'érection	434.4	drug
sildenafil —	125 271	66.5%	Augmentation de l'érection	434.4	drug
set, administration, intravascular —	112 501	16.4%	—	—	device
sertraline hydrochloride —	116 450	63.7%	Idées suicidaires	5.7	drug
sertraline —	214 801	71.6%	Tentative de suicide	6.0	drug
sensor, glucose, invasive —	115 806	1.4%	—	—	device
secukinumab —	158 767	39.8%	Arthropathie psoriasique	47.1	drug
screw —	147 842	79.9%	—	—	device
sacubitril and valsartan —	114 605	51.0%	éclaircissement de la gorge	137.4	drug
rosuvastatin —	223 851	68.3%	rhabdomyolyse	10.3	drug
rivaroxaban —	205 037	83.9%	Hémorragie interne	48.6	drug
rituximab —	215 364	88.7%	Pemphigus	325.9	drug
risperidone —	131 271	66.3%	Gynécomastie	755.0	drug
ranitidine —	230 503	93.3%	Cancer colorectal	73.6	drug
ramipril —	121 234	93.4%	Pemphigus	47.4	drug
quetiapine —	188 609	78.9%	Diabète de type 2	23.9	drug
pump, infusion, insulin, to be used with invasive glucose sensor —	415 417	8.0%	—	—	device
pump, infusion, insulin, to be used with invasive —	416 187	8.0%	—	—	device
pump, infusion, insulin —	596 309	9.1%	—	—	device
pump, infusion —	2 290 658	5.6%	—	—	device
pump set with in line "y" adapter and spike —	25 000 438	0.0%	—	—	device
pump —	4 522 200	10.3%	—	—	device
pulse generator —	254 361	55.6%	—	—	device
prosthesis, breast, noninflatable, internal, silicone gel-filled —	193 293	98.9%	—	—	device
prosthesis, breast, noninflatable, internal, silicone —	193 373	98.9%	—	—	device
prosthesis, breast, inflatable, internal, saline —	103 014	99.3%	—	—	device
prosthesis, breast —	297 602	99.0%	—	—	device
pregabalin —	267 198	66.6%	Syndrome de sevrage	9.2	drug
prednisone —	491 157	78.5%	Lupus érythémateux disséminé	20.1	drug
prednisolone oral solution —	176 279	95.5%	Infection à cytomégalovirus	21.6	drug
prednisolone oral —	176 280	95.5%	Infection à cytomégalovirus	21.6	drug
prednisolone —	188 016	93.2%	Infection à cytomégalovirus	20.7	drug
potassium chloride —	118 686	72.2%	Hypokaliémie	9.1	drug
pomalidomide —	100 554	61.3%	Myélome à plasmocytes	57.4	drug
polyethylene glycol 3350 —	98 501	41.6%	durée d'administration incorrecte du produit	28.2	drug
polyethylene glycol —	123 342	47.0%	durée d'administration incorrecte du produit	22.5	drug
phenylephrine hydrochloride —	165 690	59.0%	Réaction liée à la perfusion	11.9	drug
phenylephrine —	217 644	56.7%	Réaction liée à la perfusion	9.2	drug
permanent pacemaker electrode —	247 451	51.5%	—	—	device
pembrolizumab —	100 432	87.3%	Insuffisance surrénale	31.7	drug
pegfilgrastim —	99 745	29.5%	problème d'adhérence du dispositif	847.8	drug
pantoprazole sodium —	144 620	78.0%	Insuffisance rénale terminale	105.7	drug
pantoprazole —	323 510	81.3%	Insuffisance rénale terminale	61.2	drug
pain reliever —	247 094	87.3%	Réaction liée à la perfusion	17.5	drug
paclitaxel —	95 870	96.3%	Myélosuppression	25.6	drug
pacemaker —	713 129	45.7%	—	—	device
oxycodone hydrochloride and acetaminophen —	97 801	82.1%	Dépendance	133.7	drug
oxycodone hydrochloride —	281 587	86.9%	Dépendance médicamenteuse	194.1	drug
oxycodone —	376 208	84.2%	Dépendance médicamenteuse	131.2	drug
ondansetron tablets —	105 951	80.8%	Neutropénie fébrile	15.3	drug
ondansetron hydrochloride —	118 451	79.6%	Neutropénie fébrile	14.2	drug
ondansetron —	118 456	79.6%	Neutropénie fébrile	14.2	drug
omeprazole magnesium —	438 661	72.0%	Insuffisance rénale terminale	65.4	drug
omeprazole —	442 282	71.8%	Insuffisance rénale terminale	65.1	drug
olanzapine —	107 378	85.3%	syndrome malin des neuroleptiques	57.7	drug
non-continuous (respirator) —	273 623	20.7%	—	—	device
natalizumab —	180 199	31.2%	Symptôme général	47.9	drug
naproxen sodium —	162 972	58.3%	Synovite	37.6	drug
naproxen —	162 981	58.3%	Synovite	37.6	drug
mycophenolate mofetil hydrochloride —	131 742	91.3%	rejet de greffe	171.7	drug
mycophenolate mofetil —	131 745	91.3%	rejet de greffe	171.7	drug
morphine sulfate —	119 783	85.6%	Dépendance médicamenteuse	59.6	drug
morphine —	190 113	86.1%	Dépendance médicamenteuse	34.4	drug
montelukast sodium —	118 894	60.7%	trouble des voies respiratoires obstructives	48.4	drug
montelukast —	171 338	62.5%	Asthme	27.1	drug
monitor —	2 392 240	1.7%	—	—	device
minoxidil foam 5% (womens) —	3 436 075	75.5%	Neutropénie fébrile	8.6	drug
metoprolol tartrate —	268 317	70.6%	Fibrillation auriculaire	6.5	drug
metoprolol —	347 924	68.7%	Fibrillation auriculaire	6.3	drug
methylprednisolone —	167 055	88.8%	Réaction liée à la perfusion	15.8	drug
methotrexate sodium —	478 279	73.3%	Synovite	137.6	drug
methotrexate —	484 893	72.6%	Synovite	135.8	drug
metformin er 750 mg —	294 217	67.9%	Acidose lactique	47.4	drug
metformin er 500 mg —	294 217	67.9%	Acidose lactique	47.4	drug
metformin —	433 187	66.8%	Acidose lactique	75.1	drug
mesh, surgical —	125 850	97.0%	—	—	device
mesh —	208 370	96.5%	—	—	device
mds —	129 235	2.3%	—	—	device
magnesium —	813 618	70.5%	Insuffisance rénale terminale	49.6	drug
losartan —	206 980	63.8%	Maladie rénale chronique	6.6	drug
lorazepam —	176 559	76.9%	Suicide accompli	5.3	drug
loratadine —	113 035	44.8%	dose supplémentaire administrée	9.0	drug
lisinopril —	310 213	61.0%	angioedème	12.7	drug
levothyroxine sodium anhydrous —	97 348	69.8%	Détérioration générale de la santé physique	4.4	drug
levothyroxine sodium —	308 680	60.2%	Palpitations	3.7	drug
levonorgestrel —	205 479	32.8%	Dispositif contraceptif intra-utérin expulsé	11448.8	drug
levetiracetam —	130 496	82.8%	Résistance à plusieurs médicaments	146.4	drug
lenalidomide —	414 396	64.0%	Myélome à plasmocytes	40.2	drug
leflunomide —	102 951	82.4%	Anticorps anti-peptide cyclique citrulliné positif	1455.6	drug
lead —	466 420	70.6%	—	—	device
laryngotracheal cannula z vial inj + lidocaian 4% —	1 222 352	0.0%	—	—	device
lansoprazole —	175 073	87.3%	Insuffisance rénale terminale	143.9	drug
lamotrigine —	129 256	71.8%	Syndrome de Stevens-Johnson	21.5	drug
knee —	205 004	78.6%	—	—	device
kit —	360 069	9.8%	—	—	device
iv catheter with "y" connector —	25 000 665	0.4%	—	—	device
intraocular lens —	113 412	55.7%	—	—	device
interferon beta-1a —	191 751	53.1%	Poussée de sclérose en plaques	34.7	drug
insulin pump —	171 535	22.8%	—	—	device
insulin lispro —	137 507	46.0%	Augmentation de la glycémie	54.5	drug
insulin infusion pump / sensor augmented —	315 367	24.4%	—	—	device
insulin infusion pump —	1 112 476	15.5%	—	—	device
insulin glargine —	243 678	51.6%	Augmentation de la glycémie	26.1	drug
insulin —	492 190	55.0%	Augmentation de la glycémie	42.8	drug
instrument —	341 890	7.8%	—	—	device
infusion pump —	1 968 975	13.1%	—	—	device
infliximab —	240 611	87.5%	Pemphigus	228.2	drug
implantable lead —	123 714	69.9%	—	—	device
implantable cardioverter defibrillator —	269 031	55.9%	—	—	device
implant, endosseous, root-form —	372 575	99.8%	—	—	device
implant —	3 932 418	97.9%	—	—	device
ibuprofen tablets usp, 200mg —	195 040	72.9%	Maladie rénale chronique	6.6	drug
ibuprofen tablet, film coated —	195 036	72.9%	Maladie rénale chronique	6.6	drug
ibuprofen oral —	195 098	72.9%	Maladie rénale chronique	6.6	drug
ibuprofen capsules 200 mg —	195 145	72.9%	Maladie rénale chronique	6.6	drug
ibuprofen capsule —	198 873	72.2%	Maladie rénale chronique	6.5	drug
ibuprofen 200mg —	195 216	72.9%	Infection des voies respiratoires inférieures	10.3	drug
ibuprofen 200 mg —	195 158	72.9%	Maladie rénale chronique	6.6	drug
ibuprofen —	279 647	63.0%	Gonflement articulaire	4.7	drug
ibupfrofen —	195 038	72.9%	Maladie rénale chronique	6.6	drug
hydroxychloroquine —	149 345	78.0%	Pemphigus	408.7	drug
hydrocortisone —	121 305	79.3%	Synovite	50.7	drug
hydrocodone bitartrate —	95 444	86.2%	Trouble de l'apprentissage	194.1	drug
hydrochlorothiazide —	206 985	67.4%	Hyponatrémie	7.2	drug
huber needle w/winged ext set, 20g, 1", 8", y-site —	997 066	0.0%	—	—	device
hip —	358 427	78.4%	—	—	device
hi-flo "y" type blood pump set —	25 000 438	0.0%	—	—	device
head —	98 806	63.4%	—	—	device
guaifenesin —	199 480	55.5%	Réaction liée à la perfusion	8.7	drug
glucose sensor —	415 717	8.1%	—	—	device
glucose monitoring system —	514 797	15.7%	—	—	device
glucose monitoring sys/kit —	295 057	8.8%	—	—	device
glucose monitoring —	903 717	12.9%	—	—	device
glucose monitor —	2 330 505	1.4%	—	—	device
generator —	331 466	49.6%	—	—	device
gabapentin —	359 779	63.3%	Médicament inefficace pour une indication non approuvée	7.4	drug
furosemide —	393 086	81.3%	Insuffisance cardiaque congestive	9.3	drug
formoterol fumarate dihydrate —	114 158	57.5%	trouble des voies respiratoires obstructives	49.3	drug
formoterol fumarate —	125 520	56.1%	Asthme	27.1	drug
folic acid —	246 828	74.1%	Pemphigus	252.1	drug
fluticasone propionate and salmeterol —	99 522	50.6%	Asthme	23.2	drug
fluticasone propionate —	189 078	49.1%	Asthme	15.0	drug
fluoxetine hydrochloride —	124 895	71.6%	syndrome sérotoninergique	23.5	drug
fluoxetine —	129 920	71.4%	syndrome sérotoninergique	23.3	drug
fluoroscopic x-ray —	143 731	0.7%	—	—	device
flash glucose monitoring system —	265 623	19.9%	—	—	device
fentanyl —	113 392	85.5%	Abus de drogues	35.4	drug
femoral —	138 549	87.0%	—	—	device
famotidine —	115 334	63.6%	Insuffisance rénale terminale	22.8	drug
evolocumab —	157 026	15.6%	Dispositif difficile à utiliser	166.1	drug
etanercept —	592 886	36.0%	Synovite	58.4	drug
estradiol —	190 011	50.9%	cholécystite chronique	568.3	drug
esomeprazole magnesium —	230 681	71.5%	Insuffisance rénale terminale	120.7	drug
esomeprazole —	233 118	71.8%	Insuffisance rénale terminale	119.4	drug
escitalopram —	136 935	67.2%	Tentative de suicide	6.3	drug
ergocalciferol —	374 035	58.6%	Sinusite	4.5	drug
epinephrine —	109 279	64.4%	Sinusite	8.6	drug
endosseous dental implant —	2 968 001	99.4%	—	—	device
endosseous —	3 346 417	99.4%	—	—	device
electrode 922st 2" x 2" square 4 pk stimcare carbon cl —	4 790 810	0.0%	—	—	device
electrode —	391 326	52.5%	—	—	device
dupilumab —	438 499	11.1%	Dermatite atopique	512.8	drug
duloxetine hydrochloride —	184 178	61.5%	Syndrome de sevrage médicamenteux	11.7	drug
duloxetine —	184 186	61.5%	Syndrome de sevrage médicamenteux	11.7	drug
diphenhydramine hydrochloride —	169 045	70.1%	Réaction liée à la perfusion	22.8	drug
diphenhydramine —	195 250	68.0%	Réaction liée à la perfusion	20.0	drug
dimethyl fumarate —	122 025	33.2%	Rougeur	39.7	drug
diclofenac sodium —	153 661	60.5%	Anticorps anti-peptide cyclique citrulliné positif	582.5	drug
diclofenac —	162 477	59.7%	Anticorps anti-peptide cyclique citrulliné positif	586.8	drug
diazepam —	119 417	81.0%	Abus de drogues	17.2	drug
dextrose monohydrate —	110 136	75.1%	péritonite	16.8	drug
dextrose —	184 033	80.0%	Hypokaliémie	6.8	drug
dexamethasone 1.5 mg —	286 480	84.5%	Myélome à plasmocytes	42.3	drug
dexamethasone —	303 290	84.2%	Myélome à plasmocytes	40.7	drug
device —	1 436 117	25.2%	—	—	device
dental implant —	3 208 206	99.3%	—	—	device
denosumab —	198 114	53.8%	ostéonécrose de la mâchoire	57.0	drug
defibrillator, automatic implantable cardioverter —	117 596	68.4%	—	—	device
defibrillator —	751 871	40.1%	—	—	device
cyclosporine —	112 236	66.1%	Maladie du greffon contre l'hôte	58.0	drug
cyclophosphamide injection, solution —	172 252	96.2%	Neutropénie fébrile	36.3	drug
cyclophosphamide for injection —	172 253	96.2%	Neutropénie fébrile	36.3	drug
cyclophosphamide —	172 254	96.2%	Neutropénie fébrile	36.3	drug
crutch,quick-fit,4' 7"-6' 7",walmart —	437 238	0.0%	—	—	device
continuous glucose monitoring system —	121 156	14.6%	—	—	device
continuous glucose monitoring —	121 201	14.6%	—	—	device
continuous glucose monitor —	2 326 320	1.3%	—	—	device
clozapine —	123 200	94.7%	numération différentielle des globules blancs anormale	1445.8	drug
clopidogrel bisulfate —	99 959	86.6%	Méléna	15.8	drug
clopidogrel —	208 698	81.8%	Infarctus aigu du myocarde	12.5	drug
clonazepam —	157 182	68.1%	Suicide accompli	8.5	drug
citalopram hydrobromide —	105 394	82.2%	Suicide accompli	10.6	drug
citalopram —	134 738	77.1%	Suicide accompli	8.6	drug
ciprofloxacin hydrochloride —	95 796	83.3%	Douleur tendineuse	80.9	drug
ciprofloxacin —	95 822	83.3%	Douleur tendineuse	80.9	drug
cetirizine hydrochloride —	162 357	54.7%	Anticorps anti-peptide cyclique citrulliné positif	458.0	drug
cetirizine —	169 947	54.8%	Pemphigus	296.5	drug
certolizumab pegol —	114 573	64.7%	Anticorps anti-peptide cyclique citrulliné positif	774.8	drug
celecoxib —	129 432	70.3%	Arthropathie psoriasique	16.7	drug
catheter,foley,100%silicone,16fr,10ml,lf —	250 314	0.0%	—	—	device
catheter —	490 331	27.6%	—	—	device
carvedilol —	135 202	69.2%	Insuffisance cardiaque congestive	9.2	drug
carboplatin —	122 601	95.2%	Myélosuppression	21.4	drug
calcium —	592 039	68.4%	Diabète de type 2	25.8	drug
bupropion hydrochloride —	107 988	48.8%	Idées suicidaires	6.0	drug
bupropion —	149 152	54.9%	Suicide accompli	10.9	drug
buprenorphine —	123 005	60.8%	Analgesie inadéquate	96.6	drug
budesonide —	160 438	60.5%	Asthme	25.0	drug
blood glucose monitoring system —	111 358	6.0%	—	—	device
blood glucose monitoring —	204 724	8.2%	—	—	device
blood glucose —	243 514	9.0%	—	—	device
bisoprolol fumarate —	132 846	96.6%	hyperkaliémie	11.2	drug
bevacizumab —	126 289	88.8%	Protéinurie	33.4	drug
bed —	100 747	3.5%	—	—	device
bd needle 26g 5/8" 1ml sub-q - product#309597 —	11 625 940	100.0%	—	—	device
bd e-z scrub¿ impregnated preoperative scrub brushes (with 4% chg) - canada —	14 567 345	0.0%	—	—	device
automated insulin dosing, threshold suspend —	168 919	11.2%	—	—	device
automated insulin dosing device system, single hormonal control —	444 343	12.2%	—	—	device
atorvastatin calcium —	243 012	65.1%	Diabète de type 2	45.0	drug
atenolol —	133 343	70.3%	Bradycardie	6.9	drug
aspirin 81 mg —	502 540	71.7%	Hémorragie GI	7.1	drug
aspirin 325 mg —	500 597	71.8%	Hémorragie GI	7.1	drug
aspirin —	552 493	69.8%	Hémorragie GI	7.4	drug
artificial pancreas device system, threshold suspend —	197 524	22.8%	—	—	device
artificial pancreas device system, single hormonal control —	418 464	17.3%	—	—	device
aripiprazole —	123 730	65.0%	Trouble du jeu	549.0	drug
apremilast —	144 030	23.2%	Arthropathie psoriasique	38.3	drug
amoxicillin —	99 955	79.4%	Insuffisance rénale terminale	18.2	drug
amlodipine besylate —	166 351	69.5%	Maladie rénale chronique	5.8	drug
amlodipine —	431 535	74.3%	Maladie rénale chronique	5.8	drug
ambrisentan —	123 381	64.8%	Hypertension artérielle pulmonaire	51.4	drug
alternate controller enabled insulin infusion pump —	523 532	12.7%	—	—	device
alternate controller enabled infusion pump —	589 445	9.8%	—	—	device
alprazolam —	202 857	70.7%	Abus de drogues	16.4	drug
allopurinol —	153 758	82.1%	Goutte	19.6	drug
alendronate sodium —	100 127	78.6%	Anticorps anti-peptide cyclique citrulliné positif	710.9	drug
albuterol sulfate —	289 568	56.8%	Problème de système d'administration du dispositif	58.0	drug
albuterol —	291 471	56.8%	Problème de système d'administration du dispositif	57.7	drug
adapalene —	181 371	0.7%	Brûlure chimique de la peau	282.9	drug
adalimumab —	715 350	51.4%	Produit contre-indiqué administré	19.6	drug
acyclovir —	112 882	72.5%	Myélome à plasmocytes	13.3	drug
acetaminophen, guaifenesin, and phenylephrine hydrochloride —	156 094	59.3%	Réaction liée à la perfusion	10.8	drug
acetaminophen tablet extended release —	246 995	87.3%	Réaction liée à la perfusion	17.6	drug
acetaminophen 500mg —	247 585	87.3%	Réaction liée à la perfusion	17.6	drug
acetaminophen —	668 254	71.2%	Dépendance	21.0	drug
accessories —	150 638	23.4%	—	—	device
abatacept —	135 351	60.5%	Anticorps anti-peptide cyclique citrulliné positif	562.7	drug
96" adult exp,gse,par wye,(2)bv,lg.mask,3lf bag,3lf bag,10'x.050" mm gsl, —	18 708 026	0.0%	—	—	device
3-way "y" connector —	25 000 667	0.4%	—	—	device
22 ga iv catheter system with "y" adapter —	25 000 548	0.1%	—	—	device
1.6mm "y" plate, locking —	25 000 438	0.0%	—	—	device
(to deliver) avobenzone 3%, homosalate 5%, octisalate 10%, octocrylene 5% —	4 919 809	65.6%	Interaction médicamenteuse	3.9	drug
(to deliver) avobenzone 3%, homosalate 10%,octisalate 5%, octocrylene 5% —	5 064 083	63.8%	Interaction médicamenteuse	3.7	drug
(to deliver) avobenzone 2%, homosalate 8%, octisalate 4.5%, octocrylene 7% —	5 091 938	65.8%	Interaction médicamenteuse	3.9	drug
"z" plate —	1 994 896	5.2%	—	—	device
"y" o2 outlet —	25 000 438	0.0%	—	—	device
"y" extension set —	25 000 488	0.0%	—	—	device
"y" endotracheal tube adapter closed suction system —	25 000 438	0.0%	—	—	device
"quick fit sling" for patient lift. —	196 964	0.0%	—	—	device
"j" style bone marrow biopsy needle —	154 080	0.0%	—	—	device
"j" guidewire —	278 717	15.1%	—	—	device
.018 "guidewire" with floppy platinum tip —	130 383	0.0%	—	—	device
.014 floppy "j" wire —	686 635	15.4%	—	—	device